Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Enhertu granted Priority Review in the US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
-
Ultomiris demonstrated sustained improvements in functional activities and quality of life in adults with generalised myasthenia gravis through 60 weeks
-
AZD8233 reduced low-density lipoprotein cholesterol levels by 73% in patients with high-risk hypercholesterolemia in ETESIAN Phase IIb trial
-
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
-
AstraZeneca aims to transform the oncology treatment landscape with diverse early pipeline and novel combinations at AACR
-
Evusheld long-acting antibody combination approved in the EU for pre-exposure prophylaxis (prevention) of COVID-19 in a broad population
-
Evusheld long-acting antibody combination recommended for approval in the EU for the pre-exposure prophylaxis (prevention) of COVID-19
-
Update on CALLA Phase III trial of concurrent use of Imfinzi and chemoradiotherapy in locally advanced cervical cancer
-
AstraZeneca launches global R&D Postdoctoral Challenge to accelerate scientific discovery and diversity
-
AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomiris
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
